Del 123 i serien Handbook of Experimental Pharmacology

Glucagon III

Häftad, Engelska, 2011

1 479 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Glucagon III complements Glucagon I and II published in 1983 in this series as Vols. 66/I and II. These three volumes truly represent a "glucagon encyclopedia" and as such have no competitors in the scientific literature worldwide. In this volume, the most recent data on glucagon molecular biology are reviewed together with clinically relevant information on the role of glucagon in the pathophysiology of diabetes, the place of glucagon in medical imaging or in emergency medicine. Chapters are devoted to newly identified members of the glucagon family such as glucagon-like peptide-1 (GLP-1) and oxyntomodulin. Glucagon III is a comprehensive review of all information published on this important hormone since 1983 and is the reference book on the subject.

Produktinformation

Utgivningsdatum2011-09-26
Mått155 x 235 x 21 mm
Vikt569 g
FormatHäftad
SpråkEngelska
SerieHandbook of Experimental Pharmacology
Antal sidor349
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783642647185

Tillhör följande kategorier

1 The Industrial Production of Glucagon.- A. Introduction.- B. Production.- C. Analysis of Recombinant Human Glucagon.- D. Stability.- References.- 2 The Glucagon Gene and Its Expression.- A. Introduction.- B. Structure.- C. Expression.- D. Conclusions.- References.- 3 Preproglucagon and Its Processing.- A. Introduction.- B. Tissue-Specific Post-translational Processing of Proglucagon.- C. Role of Prohormone Convertases in Proglucagon Processing.- D. Secondary, Postsecretory Processing of Proglucagon-Derived Peptides.- E. Conclusions.- References.- 4 The Glucagon Receptor Gene: Organization and Tissue Distribution.- A. Introduction.- B. Cloning of the Glucagon Receptor.- C. Organization of the Glucagon Receptor Gene.- D. Tissue Distribution of the Glucagon Receptors.- E. Tissue Distribution of Glucagon Receptor Transcripts.- F. Regulation of Glucagon Receptor Gene Expression.- G. Structure/Function Analysis of the Glucagon Receptor.- H. Human Glucagon Receptor.- I. Conclusions.- References.- 5 Mode of Action of Glucagon Revisited.- A. Introduction.- B. Glucagon Actions Mediated Through Glucagon Receptors.- C. Glucagon is Processed by Its Target Cells.- D. Action of Mini-glucagon [Glucagon (19–29)] in Liver.- E. Mini-glucagon Action in Heart.- F. Glucagon and Mini-glucagon Act in Concert.- G. Conclusion and Perspectives.- References.- 6 Pulsatility of Glucagon.- A. Introduction.- B. Oscillations in Glucagon Plasma Levels.- C. Pulsatile Glucagon Secretion In Vitro.- D. Pulsatile Glucagon Delivery In Vitro.- E. Pulsatile Glucagon Delivery In Vivo.- F. Conclusions.- References.- 7 Glucagon and Diabetes.- A. Introduction.- B. Diabetogenic Effects of Glucagon.- C. The A Cell in Diabetes.- D. Circulating Glucagon Levels in Diabetes.- E. Glucagon Dysfunction in Diabetes.- F.Role of Glucagon Excess in the Metabolic Abnormalities of Diabetes.- G. Therapeutic Implications.- H. Conclusions.- References.- 8 The Search for Glucagon Antagonists.- A. Glucagon as a Drug Target.- B. Search for a Glucagon Antagonist.- References.- 9 Glucagon and Glucose Counterregulation.- A. Introduction.- B. Glycemic Action of Glucagon.- C. Glucagon Secretion.- D. Role of Glucagon in Glucose Counterregulation.- E. Conclusions.- References.- 10 Modes of Glucagon Administration.- A. Introduction.- B. Classic Routes of Administration.- C. New Routes of Glucagon Administration.- D. Conclusions.- References.- 11 The Place of Glucagon in Emergency Medicine.- A. Hypoglycemia.- B. Cardiovascular Insufficiency.- C. Vascular Effects.- D. Renal/Urologic Effects.- E. Shock.- F. Respiratory Effects.- G. Gastrointestinal Effects.- H. Radiographic Studies.- I. Adverse Effects.- References.- 12 The Place of Glucagon in Medical Imaging.- A. Introduction.- B. Upper Gastrointestinal Tract.- C. Small Bowel.- D. Large Bowel.- E. Biliary Tract.- F. Other Applications.- G. Side Effects and Contraindications.- References.- 13 The Glucagon Test for Evaluation of Insulin Secretion.- A. Introduction.- B. Methodological Aspects.- C. Comparison with Other Stimuli.- D. Clinical Applications.- E. Conclusions.- References.- 14 Glucagon and the Control of Appetite.- A. Introduction.- B. Prandial Glucagon Secretion.- C. Glucagon Administration and Food Intake.- D. Glucagon Antagonism and Food Intake.- E. Mechanism of Glucagon Satiety.- F. Clinical Aspects.- G. Conclusions.- References.- 15 Glucagonoma and Its Management.- A. Introduction.- B. Diagnosis and Localization of the Tumor.- C. Management of the Glucagonoma Syndrome.- D. Prognosis.- E. Conclusions.- References.- 16 Structure and Functionof the Glucagon-Like Peptide-1 Receptor.- A. Introduction.- B. GLP-1 Receptor.- C. Conclusions.- References.- 17 Physiology and Pathophysiology of GLP-1.- A. The Incretin Concept.- B. Origin, Processing, Secretion and Fate of GLP-1.- C. Tissue Distribution of GLP-1 Receptors and Biological Actions.- D. Signal Transduction of the GLP-1 Receptor.- E. Pathophysiological Relevance?.- References.- 18 Potential of GLP-1 in Diabetes Management.- A. Introduction.- B. Actions of GLP-1 on Blood Glucose in Humans.- C. Gastrointestinal Effects of GLP-1 in Humans.- D. GLP-1 and Diabetes.- E. GLP-1 Metabolism in Normal and Diabetic Subjects.- F. Conclusion and Outlook.- References.- 19 Oxyntomodulin and Its Related Peptides.- A. Introduction.- B. Biological Characteristics of Oxyntomodulin.- C. Conclusions.- References.

Mer från samma författare

New Aspects in Diabetes

Pierre J. Lefèbvre, Eberhard Standl

Inbunden, 1992

2 159 kr

Diabetes Mellitus: Pathophysiology and Therapy

Werner Creutzfeldt, Pierre J. Lefebvre

Häftad, 1989

1 479 kr

Pathology of the Endocrine Pancreas in Diabetes

Pierre J. Lefebvre, Daniel G. Pipeleers

Häftad, 2011

1 479 kr

Mer från samma serie

Estrogens and Antiestrogens I

Michael Oettel, Ekkehard Schillinger

Häftad, 2012

4 419 kr

Del 247

Delta Opioid Receptor Pharmacology and Therapeutic Applications

Emily M. Jutkiewicz

Häftad, 2018

1 699 kr

Del 246

Voltage-gated Sodium Channels: Structure, Function and Channelopathies

Mohamed Chahine

Häftad, 2019

2 209 kr

Del 249

Mechanisms of Drug Resistance in Cancer Therapy

Mario Mandalà, Emanuela Romano

Inbunden, 2019

2 209 kr

Del 251

Brown Adipose Tissue

Alexander Pfeifer, Martin Klingenspor, Stephan Herzig

Inbunden, 2019

2 939 kr

Del 252

New Psychoactive Substances

Hans H. Maurer, Simon D. Brandt

Inbunden, 2019

2 499 kr

Antidepressants

Matthew Macaluso, Sheldon H. Preskorn

Inbunden, 2019

2 209 kr

Sleep-Wake Neurobiology and Pharmacology

Hans-Peter Landolt, Derk-Jan Dijk

Inbunden, 2019

2 209 kr

Del 254

Nociceptin/Orphanin FQ Peptide Receptor

Mei-Chuan Ko, Girolamo Caló

Inbunden, 2019

2 209 kr

Del 254

Nociceptin/Orphanin FQ Peptide Receptor

Mei-Chuan Ko, Girolamo Caló

Häftad, 2020

2 209 kr

Du kanske också är intresserad av

Diabetes Mellitus: Pathophysiology and Therapy

Werner Creutzfeldt, Pierre J. Lefebvre

Häftad, 1989

1 479 kr

Pathology of the Endocrine Pancreas in Diabetes

Pierre J. Lefebvre, Daniel G. Pipeleers

Häftad, 2011

1 479 kr

New Aspects in Diabetes

Pierre J. Lefèbvre, Eberhard Standl

Inbunden, 1992

2 159 kr

Ruth Kvarnström-Jones - Systrarna på Sophiahemmet, Inbunden

Nyhet

Del 3

Systrarna på Sophiahemmet

Ruth Kvarnström-Jones

Inbunden, 2026

299 kr329 kr

Nyhet

Del 11

Medusa

Lars Kepler

Inbunden, 2026

289 kr319 kr

Nyhet

Threshing Day (Limited Deluxe Edition)

Rebecca Yarros

Inbunden, 2026

339 kr

Here Where We Live Is Our Country: The Story of the Jewish Bund

Molly Crabapple

Inbunden, 2026

419 kr

Sarah J. Maas - A Court of Splintered Harmony, Häftad

Nyhet

Del 6

A Court of Splintered Harmony

Sarah J. Maas

Häftad, 2026

259 kr

Del 1

Sly

Sara Strömberg

Pocket, 2022

79 kr129 kr

Del 3

Skinn

Sara Strömberg

Pocket, 2024

79 kr129 kr

Del 123 i serien Handbook of Experimental Pharmacology

Glucagon III

Häftad, Engelska, 2011

AvPierre J. Lefebvre,Pierre J. Lefebvre

1 479 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Produktinformation

Utgivningsdatum2011-09-26
Mått155 x 235 x 21 mm
Vikt569 g
FormatHäftad
SpråkEngelska
SerieHandbook of Experimental Pharmacology
Antal sidor349
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783642647185

Tillhör följande kategorier

1 The Industrial Production of Glucagon.- A. Introduction.- B. Production.- C. Analysis of Recombinant Human Glucagon.- D. Stability.- References.- 2 The Glucagon Gene and Its Expression.- A. Introduction.- B. Structure.- C. Expression.- D. Conclusions.- References.- 3 Preproglucagon and Its Processing.- A. Introduction.- B. Tissue-Specific Post-translational Processing of Proglucagon.- C. Role of Prohormone Convertases in Proglucagon Processing.- D. Secondary, Postsecretory Processing of Proglucagon-Derived Peptides.- E. Conclusions.- References.- 4 The Glucagon Receptor Gene: Organization and Tissue Distribution.- A. Introduction.- B. Cloning of the Glucagon Receptor.- C. Organization of the Glucagon Receptor Gene.- D. Tissue Distribution of the Glucagon Receptors.- E. Tissue Distribution of Glucagon Receptor Transcripts.- F. Regulation of Glucagon Receptor Gene Expression.- G. Structure/Function Analysis of the Glucagon Receptor.- H. Human Glucagon Receptor.- I. Conclusions.- References.- 5 Mode of Action of Glucagon Revisited.- A. Introduction.- B. Glucagon Actions Mediated Through Glucagon Receptors.- C. Glucagon is Processed by Its Target Cells.- D. Action of Mini-glucagon [Glucagon (19–29)] in Liver.- E. Mini-glucagon Action in Heart.- F. Glucagon and Mini-glucagon Act in Concert.- G. Conclusion and Perspectives.- References.- 6 Pulsatility of Glucagon.- A. Introduction.- B. Oscillations in Glucagon Plasma Levels.- C. Pulsatile Glucagon Secretion In Vitro.- D. Pulsatile Glucagon Delivery In Vitro.- E. Pulsatile Glucagon Delivery In Vivo.- F. Conclusions.- References.- 7 Glucagon and Diabetes.- A. Introduction.- B. Diabetogenic Effects of Glucagon.- C. The A Cell in Diabetes.- D. Circulating Glucagon Levels in Diabetes.- E. Glucagon Dysfunction in Diabetes.- F.Role of Glucagon Excess in the Metabolic Abnormalities of Diabetes.- G. Therapeutic Implications.- H. Conclusions.- References.- 8 The Search for Glucagon Antagonists.- A. Glucagon as a Drug Target.- B. Search for a Glucagon Antagonist.- References.- 9 Glucagon and Glucose Counterregulation.- A. Introduction.- B. Glycemic Action of Glucagon.- C. Glucagon Secretion.- D. Role of Glucagon in Glucose Counterregulation.- E. Conclusions.- References.- 10 Modes of Glucagon Administration.- A. Introduction.- B. Classic Routes of Administration.- C. New Routes of Glucagon Administration.- D. Conclusions.- References.- 11 The Place of Glucagon in Emergency Medicine.- A. Hypoglycemia.- B. Cardiovascular Insufficiency.- C. Vascular Effects.- D. Renal/Urologic Effects.- E. Shock.- F. Respiratory Effects.- G. Gastrointestinal Effects.- H. Radiographic Studies.- I. Adverse Effects.- References.- 12 The Place of Glucagon in Medical Imaging.- A. Introduction.- B. Upper Gastrointestinal Tract.- C. Small Bowel.- D. Large Bowel.- E. Biliary Tract.- F. Other Applications.- G. Side Effects and Contraindications.- References.- 13 The Glucagon Test for Evaluation of Insulin Secretion.- A. Introduction.- B. Methodological Aspects.- C. Comparison with Other Stimuli.- D. Clinical Applications.- E. Conclusions.- References.- 14 Glucagon and the Control of Appetite.- A. Introduction.- B. Prandial Glucagon Secretion.- C. Glucagon Administration and Food Intake.- D. Glucagon Antagonism and Food Intake.- E. Mechanism of Glucagon Satiety.- F. Clinical Aspects.- G. Conclusions.- References.- 15 Glucagonoma and Its Management.- A. Introduction.- B. Diagnosis and Localization of the Tumor.- C. Management of the Glucagonoma Syndrome.- D. Prognosis.- E. Conclusions.- References.- 16 Structure and Functionof the Glucagon-Like Peptide-1 Receptor.- A. Introduction.- B. GLP-1 Receptor.- C. Conclusions.- References.- 17 Physiology and Pathophysiology of GLP-1.- A. The Incretin Concept.- B. Origin, Processing, Secretion and Fate of GLP-1.- C. Tissue Distribution of GLP-1 Receptors and Biological Actions.- D. Signal Transduction of the GLP-1 Receptor.- E. Pathophysiological Relevance?.- References.- 18 Potential of GLP-1 in Diabetes Management.- A. Introduction.- B. Actions of GLP-1 on Blood Glucose in Humans.- C. Gastrointestinal Effects of GLP-1 in Humans.- D. GLP-1 and Diabetes.- E. GLP-1 Metabolism in Normal and Diabetic Subjects.- F. Conclusion and Outlook.- References.- 19 Oxyntomodulin and Its Related Peptides.- A. Introduction.- B. Biological Characteristics of Oxyntomodulin.- C. Conclusions.- References.